Format

Send to

Choose Destination
Eur J Contracept Reprod Health Care. 2018 Aug;23(4):303-308. doi: 10.1080/13625187.2018.1499892. Epub 2018 Sep 10.

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.

Author information

1
a Family Health International (FHI 360) , Washington , DC , USA.
2
b Family Health International (FHI 360) , Durham , NC , USA.
3
c Family Health International (FHI 360) , Nairobi , Kenya.
4
d Austin, TX, USA, formerly with Family Health International (FHI 360) , Durham , NC , USA.
5
e Family Health Options Kenya (FHOK) , Nairobi , Kenya.

Abstract

OBJECTIVES:

The levonorgestrel-releasing intrauterine system (LNG-IUS) is an underused contraceptive method in sub-Saharan Africa. A recent market assessment in Kenya found that if a more affordable version of the method were available it may increase demand and uptake of the method. We therefore aimed to examine attitudes and perceptions around the LNG-IUS and experiences of method use, including exploring attributes such as bleeding changes, contraceptive-related amenorrhoea and perceived non-contraceptive benefits.

METHODS:

Qualitative interviews were conducted among 29 women who were current or recent users of the LNG-IUS, and among a subset (nā€‰=ā€‰9) of their husbands/partners.

RESULTS:

Our findings indicate that women's main reason for choosing the LNG-IUS for contraception was their perception that the method had fewer side effects compared with other contraceptive methods. Women had favourable attitudes towards using the LNG-IUS. Husbands were also very positive about their partner's use of the method.

CONCLUSION:

Understanding the motivations and experiences of early adopters of the LNG-IUS can help inform the development of demand creation and communication strategies to influence uptake and continuation of the LNG-IUS both in Kenya and perhaps more broadly. Communication efforts that emphasise the positive attributes of the LNG-IUS could help promote wider use of the method, especially if new, more affordable product(s) become available.

KEYWORDS:

Kenya; LARC; LNG-IUS; Mirena; levonorgestrel-releasing intrauterine system; long-acting reversible contraception; partner perspective

PMID:
30198796
PMCID:
PMC6191886
DOI:
10.1080/13625187.2018.1499892
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center